Albumin for septic shock after surgery
Treatments studied
Part of Infections clinical trials.
This trial tests if giving human albumin (a protein fluid) can help treat septic shock in surgical intensive care patients. If you have severe infection and very low blood pressure after surgery, this treatment might improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and in the surgical ICU after a recent surgery.
- You have a serious infection that needed surgery within 2 days of entering the ICU.
- You have septic shock: a very low blood pressure that doesn't improve with fluids or you need strong medicines to keep it up.
- You have signs that your body's organs are struggling, like high lactate levels, low urine output, or other organ failure symptoms.
- You do not have conditions that already require albumin, such as liver disease or severe burns, and you are not allergic to albumin.
- You are not pregnant or breastfeeding, and you don't have severe fluid overload or kidney failure needing dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a concentrated protein solution (albumin 20%) early in septic shock helps better than standard fluids (crystalloids). It's for people who have been in septic shock less than 24 hours and still need blood pressure support.
This trial tests whether giving albumin instead of standard crystalloid fluids helps adults with septic shock. It may improve how well your body circulates blood and reduces strain on organs.
This trial tests whether giving albumin (a blood protein through an IV) can improve recovery after acute kidney injury in people who are in the ICU and need kidney support treatment. It mainly aims to help the kidneys bounce back better after this serious illness.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This study is for adults in the intensive care unit with septic shock (a severe infection that drops blood pressure). It looks at how well your body holds fluid and whether treatment can be safely reduced.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.